Back to Results
First PageMeta Content
Amides / Eptifibatide / Guanidines / Indoles / lactams / Antiplatelet drug / Gemcitabine / Lung cancer / Chemistry / gpIIb/IIIa inhibitors / Organic chemistry


PRESS RELEASE Sanofi Provides Update on Phase 3 Studies of Two Investigational Compounds Paris, France - June 3, [removed]Sanofi (EURONEXT: SAN and NYSE: SNY) today announced topline results of two Phase 3 clinical studie
Add to Reading List

Document Date: 2014-10-09 15:26:45


Open Document

File Size: 25,37 KB

Share Result on Facebook
UPDATE